Synapsoft logo
AI Insights from Disclosures
Searching...
Celestra Inc. 352770
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Celestra Inc. engages in the business of developing and commercializing early diagnosis service technologies for cancer and other diseases through genome-based biohealth information processing, technology for simultaneously detecting CTC and cfDNA in blood, and multi-omics analysis technology. Specifically, the company's technology and business are classified into four areas: genome-based healthcare, liquid biopsy platform, cancer diagnosis/monitoring, and early cancer diagnosis.
Representative Director Baek Seohyeon
Founded June 21, 2011
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 13581-0198797
Business number 135-86-16587
Phone Number 070-8286-6966
Fax Number 031-8066-7274
Company Address 7-3 Gwanggyojungang-ro 248beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant